4th Quarter - Report

FORBES-TATE for AMGEN USA, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Issues related to H.R. 748 - the CARES Act (Pub.L. 116-136); Issues related to H.R. 925 - The Heroes Act.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 748 (116th), H.R. 925 (116th)

Medical/Disease Research/Clinical Labs MED

Issues related to Biosimilars.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Issues related to the implementation of international tax and tax reform; Issues related to Puerto Rico tax.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to prescription drug pricing; Issues related to H.R. 2693.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2693 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.